[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65:87-108.
[2] Marquardt JU, Andersen JB, Thorgeirsson SS. Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer, 2015, 15:653-667.
[3] Wang M, Li W, Xing X, et al. BRCA1 and STMN1 as prognostic markers in NSCLCs who received cisplatin-based adjuvant chemo-therapy. Oncotarget, 2017, 8:80869-80877.
[4] Parton RG, del Pozo MA. Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol, 2013, 14:98-112.
[5] Guerrero S, Diaz-Garcia VM, Contreras-Orellana P, et al. Gold nanoparticles as tracking devices to shed light on the role of caveolin-1 in early stages of melanoma metastasis. Nanomedicine (Lond), 2018, 13:1447-1462.
[6] Zhang HQ, Guo X, Guo SQ, et al. STMN1 in colon cancer: expression and prognosis in Chinese patients. Eur Rev Med Pharmacol Sci, 2016, 20:2038-2044.
[7] Ke B, Wu LL, Liu N, et al. Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer. Tumour Biol, 2013, 34:3137-3145.
[8] Tan HT, Wu W, Ng YZ, et al. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker. J Proteome Res, 2012, 11:1433-1445.
[9] Tse EY, Ko FC, Tung EK, et al. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis. J Pathol. 2012, 226:645-653. |
